# Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

> **NCT00774852** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 137 (actual)

## Conditions studied

- Lupus Nephritis
- Lupus Erythematosus, Systemic

## Interventions

- **DRUG:** abatacept
- **DRUG:** cyclophosphamide
- **DRUG:** azathioprine
- **DRUG:** prednisone
- **DRUG:** abatacept placebo
- **DRUG:** azathioprine placebo

## Key facts

- **NCT ID:** NCT00774852
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2012-12
- **Final completion:** 2014-06
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2016-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00774852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00774852, "Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00774852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*